Veratrum: Difference between revisions
Rabin Bista (talk | contribs) No edit summary |
m Protected "Veratrum": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
(5 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
{{DrugProjectFormSinglePage | {{DrugProjectFormSinglePage | ||
|authorTag=<!--Overview--> | |authorTag=<!--Overview-->{{RB}} | ||
|OTC= | |OTC=Yes | ||
|genericName=Veratrum | |||
|aOrAn=a | |aOrAn=a | ||
| | |drugClass=OTC | ||
| | |indicationType=treatment | ||
| | |indication=acute self-limiting conditions according to standard homeopathic indications | ||
|adverseReactions=<!--Black Box Warning--> | |adverseReactions=<!--Black Box Warning--> | ||
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | |blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | ||
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | |blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | ||
<!--Adult Indications and Dosage--> | <!--Adult Indications and Dosage--> | ||
<!--FDA-Labeled Indications and Dosage (Adult)--> | <!--FDA-Labeled Indications and Dosage (Adult)--> | ||
|fdaLIADAdult===== | |fdaLIADAdult=====Indications==== | ||
* To be used for acute self-limiting conditions according to standard homeopathic indications | |||
* | ====Purpose==== | ||
* [[Diarrhea]] , [[Vomiting]] | |||
====Dosage==== | |||
* Take at onset of symptoms. Repeat every 2 hours or as needed until relieved. If condition persists or worsens discontinue use and consult a practitioner. | |||
===== | =====Adults===== | ||
* dissolve 5-10 pellets in 1 oz. of filtered water or take dry by mouth. | |||
* | =====Children and infants===== | ||
* 1-5 pellets. | |||
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
===== | |||
* | |||
|offLabelAdultGuideSupport= | |||
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
<!--Non–Guideline-Supported Use (Adult)--> | <!--Non–Guideline-Supported Use (Adult)--> | ||
|offLabelAdultNoGuideSupport= | |offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | ||
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients. | |||
<!--Pediatric Indications and Dosage--> | <!--Pediatric Indications and Dosage--> | ||
<!--FDA-Labeled Indications and Dosage (Pediatric)--> | <!--FDA-Labeled Indications and Dosage (Pediatric)--> | ||
|fdaLIADPed= | |fdaLIADPed=There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients. | ||
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients. | |||
<!--Off-Label Use and Dosage (Pediatric)--> | <!--Off-Label Use and Dosage (Pediatric)--> | ||
<!--Guideline-Supported Use (Pediatric)--> | <!--Guideline-Supported Use (Pediatric)--> | ||
|offLabelPedGuideSupport= | |offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | ||
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | |||
<!--Non–Guideline-Supported Use (Pediatric)--> | <!--Non–Guideline-Supported Use (Pediatric)--> | ||
|offLabelPedNoGuideSupport= | |offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | ||
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients. | |||
<!--Contraindications--> | <!--Contraindications--> | ||
|contraindications= | |contraindications=<!--Warnings--> | ||
|warnings=* If pregnant or nursing, consult a practitioner before using. | |||
<!--Warnings--> | * Keep these and all medications out of the reach of children. | ||
|warnings=* | |||
* | |||
<!--Adverse Reactions--> | <!--Adverse Reactions--> | ||
Line 126: | Line 55: | ||
<!--Clinical Trials Experience--> | <!--Clinical Trials Experience--> | ||
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label. | |clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label. | ||
Line 193: | Line 60: | ||
<!--Postmarketing Experience--> | <!--Postmarketing Experience--> | ||
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label. | |postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label. | ||
<!--Drug Interactions--> | <!--Drug Interactions--> | ||
|drugInteractions= | |drugInteractions=<!--Use in Specific Populations--> | ||
|useInPregnancyFDA=* If pregnant or nursing, consult a practitioner before using. | |||
<!--Use in Specific Populations--> | |||
|useInPregnancyFDA=* | |||
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | |useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | ||
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant. | There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant. | ||
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery. | |useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery. | ||
|useInNursing= | |useInNursing=* If pregnant or nursing, consult a practitioner before using. | ||
|useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients. | |useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients. | ||
|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients. | |useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients. | ||
Line 268: | Line 83: | ||
<!--Administration and Monitoring--> | <!--Administration and Monitoring--> | ||
|administration=* Oral | |administration=* Oral | ||
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label. | |||
<!--IV Compatibility--> | <!--IV Compatibility--> | ||
Line 278: | Line 91: | ||
<!--Overdosage--> | <!--Overdosage--> | ||
|overdose= | |overdose=There is limited information regarding <i>Overdose</i> of {{PAGENAME}} in the drug label. | ||
<!--Pharmacology--> | |||
<!--Drug box 2--> | |||
|drugBox=: [[File:Veratrum Wiki Str.png|thumb|none|600px|This image is provided by the Wikipedia.]] | |||
<!--Mechanism of Action--> | |||
|mechAction= | |||
<!--Structure--> | |||
|structure======ACTIVE INGREDIENT===== | |||
* VERATRUM ALBUM | |||
=====INACTIVE INGREDIENTS===== | |||
* Inactive Ingredients - Lactose, Sucrose | |||
<!--Pharmacodynamics--> | <!--Pharmacodynamics--> | ||
Line 316: | Line 125: | ||
<!--How Supplied--> | <!--How Supplied--> | ||
|howSupplied= | |howSupplied= | ||
|packLabel=<!--Patient Counseling Information--> | |packLabel=====PACKAGE LABEL==== | ||
Est. No. 1724217 | |||
Natural Health Supply | |||
505-474-9175 | |||
Homeopathic Medicated Pellets | |||
Do not use if clear bottle seal is broken | |||
VERATRUM ALBUM 30C | |||
Diarrhea Vomiting | |||
Lot #__________________ | |||
: [[File:Veratrum PDP.png|thumb|none|600px|This image is provided by the National Library of Medicine.]] | |||
====Ingredients and Appearance==== | |||
: [[File:Veratrum Ing and App.png|thumb|none|600px|This image is provided by the National Library of Medicine.]] | |||
<!--Patient Counseling Information--> | |||
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label. | |fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label. | ||
Line 324: | Line 158: | ||
<!--Brand Names--> | <!--Brand Names--> | ||
|brandNames=* | |brandNames=* DIARRHEA VOMITING®<ref>{{Cite web | title = Veratrum album | url = http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a341ec4-5fb9-4829-95a8-09c5964b9833}}</ref> | ||
<!--Look-Alike Drug Names--> | <!--Look-Alike Drug Names--> | ||
|drugShortage= | |drugShortage= | ||
}} | }} | ||
<!--Pill Image--> | <!--Pill Image--> |
Latest revision as of 17:23, 20 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rabin Bista, M.B.B.S. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Overview
Veratrum is a OTC that is FDA approved for the treatment of acute self-limiting conditions according to standard homeopathic indications. Common adverse reactions include .
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Indications
- To be used for acute self-limiting conditions according to standard homeopathic indications
Purpose
Dosage
- Take at onset of symptoms. Repeat every 2 hours or as needed until relieved. If condition persists or worsens discontinue use and consult a practitioner.
Adults
- dissolve 5-10 pellets in 1 oz. of filtered water or take dry by mouth.
Children and infants
- 1-5 pellets.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Veratrum in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Veratrum in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding FDA-Labeled Use of Veratrum in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Veratrum in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Veratrum in pediatric patients.
Contraindications
There is limited information regarding Veratrum Contraindications in the drug label.
Warnings
- If pregnant or nursing, consult a practitioner before using.
- Keep these and all medications out of the reach of children.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Veratrum in the drug label.
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Veratrum in the drug label.
Drug Interactions
There is limited information regarding Veratrum Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
- If pregnant or nursing, consult a practitioner before using.
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Veratrum in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Veratrum during labor and delivery.
Nursing Mothers
- If pregnant or nursing, consult a practitioner before using.
Pediatric Use
There is no FDA guidance on the use of Veratrum with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Veratrum with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Veratrum with respect to specific gender populations.
Race
There is no FDA guidance on the use of Veratrum with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Veratrum in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Veratrum in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Veratrum in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Veratrum in patients who are immunocompromised.
Administration and Monitoring
Administration
- Oral
Monitoring
There is limited information regarding Monitoring of Veratrum in the drug label.
IV Compatibility
There is limited information regarding IV Compatibility of Veratrum in the drug label.
Overdosage
There is limited information regarding Overdose of Veratrum in the drug label.
Pharmacology
Mechanism of Action
There is limited information regarding Veratrum Mechanism of Action in the drug label.
Structure
ACTIVE INGREDIENT
- VERATRUM ALBUM
INACTIVE INGREDIENTS
- Inactive Ingredients - Lactose, Sucrose
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Veratrum in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Veratrum in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Veratrum in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Veratrum in the drug label.
How Supplied
There is limited information regarding Veratrum How Supplied in the drug label.
Storage
There is limited information regarding Veratrum Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Veratrum |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
PACKAGE LABEL
Est. No. 1724217
Natural Health Supply
505-474-9175
Homeopathic Medicated Pellets
Do not use if clear bottle seal is broken
VERATRUM ALBUM 30C
Diarrhea Vomiting
Lot #__________________
Ingredients and Appearance
{{#ask: Label Page::Veratrum |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Veratrum in the drug label.
Precautions with Alcohol
- Alcohol-Veratrum interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- DIARRHEA VOMITING®[1]
Look-Alike Drug Names
There is limited information regarding Veratrum Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.